We are live on ! Find out more
KLDO

Kaleido Biosciences, Inc. Common Stock
KLDO

Delisted

KLDO was delisted on the 14th of April, 2022.

Back to rankings

61 hedge funds and large institutions have $273M invested in Kaleido Biosciences, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

9% more funds holding

Funds holding: 56 → 61 (+5)

15% less capital invested

Capital invested by funds: $320M → $273M (-$47.9M)

Holders
61
Holders Change
+5
Holders Change %
+8.93%
% of All Funds
1.08%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
13
Increased
16
Reduced
9
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.44M
2
BlackRock
BlackRock
New York
+$3.32M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$844K
4
Millennium Management
Millennium Management
New York
+$356K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$314K

Top Sellers

Rank Fund Capital Flow
1
HP
Harbourvest Partners
Massachusetts
-$707K
2
MAM
Martingale Asset Management
Massachusetts
-$345K
3
Squarepoint
Squarepoint
New York
-$267K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$223K
5
Two Sigma Investments
Two Sigma Investments
New York
-$144K
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$176M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$33.6M +$4.44M +541,300 +17%
HP
3
Harbourvest Partners
Massachusetts
$16.7M -$707K -86,195 -4%
BlackRock
4
BlackRock
New York
$8.54M +$3.32M +404,988 +76%
PAI
5
Palo Alto Investors
California
$7.16M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$5.91M +$844K +102,844 +19%
AG
7
Artal Group
Luxembourg
$4.55M – – –
Federated Hermes
8
Federated Hermes
Pennsylvania
$4.55M – – –
Baillie Gifford & Co
9
Baillie Gifford & Co
United Kingdom
$4M – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$1.91M +$314K +38,220 +22%
Northern Trust
11
Northern Trust
Illinois
$1.84M +$4.11K +501 +0.2%
State Street
12
State Street
Massachusetts
$1.72M +$176K +21,500 +13%
TOCUITCONY
13
Trustees of Columbia University in the City of New York
New York
$1.37M +$1.23M +150,150 New
Charles Schwab
14
Charles Schwab
California
$825K -$39.8K -4,850 -5%
N
15
Nuveen
North Carolina
$603K +$74.5K +9,085 +16%
Millennium Management
16
Millennium Management
New York
$395K +$356K +43,364 New
First Trust Advisors
17
First Trust Advisors
Illinois
$349K -$10.2K -1,247 -3%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$344K +$50.5K +6,156 +19%
SFI
19
Susquehanna Fundamental Investments
Pennsylvania
$222K +$53.7K +6,543 +37%
Morgan Stanley
20
Morgan Stanley
New York
$203K +$98.2K +11,975 +115%
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$160K – – –
State of Wisconsin Investment Board
22
State of Wisconsin Investment Board
Wisconsin
$149K +$135K +16,400 New
BII
23
Bainco International Investors
Massachusetts
$132K – – –
AllianceBernstein
24
AllianceBernstein
Tennessee
$125K – – –
Goldman Sachs
25
Goldman Sachs
New York
$125K +$113K +13,778 New
1
2 3

KLDO Hedge Fund Activity: Q4 2020 in Review

61 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Kaleido Biosciences, Inc. Common Stock (KLDO) for Q4 2020, worth a combined $273M — down 15% from $320M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new KLDO positions and 8 closed out — a net gain of 5 holders — while 16 added to existing stakes and 9 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $4.44M. The largest seller was Harbourvest Partners, cutting an estimated $707K.

  • 61 institutional investors held Kaleido Biosciences, Inc. Common Stock (KLDO) as of Q4 2020, up from 56 in Q3 2020.
  • Funds reported $273M of Kaleido Biosciences, Inc. Common Stock stock for Q4 2020, down 15% quarter-over-quarter.
  • 13 funds opened new Kaleido Biosciences, Inc. Common Stock positions in Q4 2020 and 8 closed out, a net change of +5 holders.
  • The largest Kaleido Biosciences, Inc. Common Stock buyer in Q4 2020 was Fidelity Investments, an estimated $4.44M added.
  • The largest Kaleido Biosciences, Inc. Common Stock seller in Q4 2020 was Harbourvest Partners, an estimated $707K sold.

Based on aggregated 13F filings for Q4 2020.